AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Headline
AHA and the Institute for Diversity and Health Equity released the fifth and final installment in its five-part DEI Data Insights series, which highlights…
Chairperson's File
We know that health equity matters. But what exactly does the term mean? AHA’s Institute for Diversity and Health Equity defines “health equity” as “The fair…
Headline
A federal court in Texas last week found that the Federal Trade Commission likely lacked statutory authority to issue its Non-Compete Clause Final Rule. The…
Headline
The Supreme Court June 28 overturned a 1984 ruling in Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., which required courts to defer to…
Headline
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal…
Headline
The Supreme Court June 27 dismissed a case about whether an Idaho law can coexist with the federal Emergency Medical Treatment and Active Labor Act (EMTALA),…